A short medical news share notes that as GLP-1 use spreads, the effects on frail patients are still not well understood.
Recap by typeshit. Post by Facebook on Facebook.
2:21
The Las Vegas station covers Lilly's experimental retatrutide and why researchers see it as a potential step up in weight loss.
Function Health points out that the body produces GLP-1 itself and lists ways it says can boost it. The claims are the company's own.
Popular Mechanics traces how her 1980s work at Mass General showed GLP-1 triggers insulin release. Gallup now puts GLP-1 weight loss use at about 11% of Americans.
32:59
Tatem discusses tesamorelin and his view that it can reshape the body without moving the scale. Treat the claims as his own, not settled fact.
Barzilai highlights trial results on retatrutide in adults with sleep apnea and obesity or overweight, a new use being tested for Lilly's drug.
A lighthearted Friday post from Saroni about friends refusing to believe her answer on how she lost weight. No details on the drug itself.
Loading…